Data as of Dec 19
| +0.077 / +9.37%|
The 2 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 5.27, with a high estimate of 6.00 and a low estimate of 4.53. The median estimate represents a +485.65% increase from the last price of 0.90.
The current consensus among 1 polled investment analysts is to Buy stock in DelMar Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.